Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$670,734
+$25,168 QoQ
Shares Held
2,641
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#3,400
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mathes Company, Inc. holds $5,421,408 across 7 Drug Manufacturers - General names. JNJ ranks #5 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
48,623 | $1,170,841 | |
| 2 | AMGN |
Amgen Inc
|
3,095 | $1,120,761 | |
| 3 | LLY |
ELI LILLY & Co
|
772 | $925,960 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
5,500 | $694,870 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
2,641 | $670,734 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,565 | $586,602 | |
| 7 | ABBV |
AbbVie Inc.
|
1,000 | $251,640 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $670,734 | 2,641 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $645,566 | 2,641 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $410,381 | 1,983 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $367,687 | 1,983 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $312,068 | 2,043 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $338,811 | 2,043 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $518,462 | 3,585 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $3,240,389 | 19,995 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,930,361 | 20,049 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,171,551 | 20,049 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $3,152,198 | 20,111 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $3,152,380 | 20,240 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $3,336,717 | 20,159 | Shares | Sole | 2023-07-25 | |
| 2022-12-31 | $3,570,803 | 20,214 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $3,309,510 | 20,259 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $3,609,488 | 20,334 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $3,680,003 | 20,764 | Shares | Sole | 2022-06-15 | |
| 2021-12-31 | $3,706,060 | 21,664 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $3,547,186 | 21,964 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $3,766,615 | 22,864 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $3,858,773 | 23,479 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $3,712,908 | 23,592 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $3,430,492 | 23,042 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $3,458,372 | 24,592 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $3,371,614 | 25,712 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||